Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Contact Lenses pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Contact Lenses is a corrective, cosmetic or therapeutic lens which is placed on the cornea of the eye.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Contact Lenses under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Contact Lenses under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Contact Lenses Overview
Products under Development
Contact Lenses - Pipeline Products by Stage of Development
Table Figure 1: Contact Lenses - Pipeline Products by Stage of Development
Table Contact Lenses - Pipeline Products by Stage of Development
Contact Lenses - Pipeline Products by Segment
Table Figure 2: Contact Lenses - Pipeline Products by Segment
Table Contact Lenses - Pipeline Products by Segment
Contact Lenses - Pipeline Products by Territory
Table Figure 3: Contact Lenses - Pipeline Products by Territory
Table Contact Lenses - Pipeline Products by Territory
Contact Lenses - Pipeline Products by Regulatory Path
Table Myolens - An Open Label, 3 Arms, Multicenter, Randomized. To Evaluate the Effectiveness Fitlens Soft Central Near and Central Far Contact Lens, Compared With MiSight for the Control of Progressive Juvenile Onset Myopia in Children Ages 8-12
Table NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens - Myopia Control in the Pediatric Population: A Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05%
Table NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens - Myopia Progression in Children and Adolescents Before and after Use of a Novel Extended Depth of Focus Daily Disposable Soft Contact Lens
Feb 27, 2023: Menicon Notice Regarding Change in Representative Executive Officers and Personnel Changes in Executive Officers
Feb 23, 2023: Fielmann Announces Preliminary Figures for FY2022/Dividend
Feb 23, 2023: EssilorLuxotticaFY 2022 Results Year of records in sales, operating and net profit
Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
Feb 02, 2023: Cooper Companies Announces Release Date for First Quarter 2023
Feb 01, 2023: Novartis Announces Annual Report 2022
Feb 01, 2023: Newly launched multifocal colored contact lens 2WEEK Menicon Rei multifocal realizes natural vision from near to distance
Jan 31, 2023: Hoya Announces Fourth semi-annual financial statements
Jan 30, 2023: Yael Kusch Appointed Global Public Relations Manager Of Essilorluxottica
Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
Dec 19, 2022: CooperCompanies Sets Annual Meeting and Stockholder Record Dates
Nov 30, 2022: Elegance Optical International Holdings announces Interim Results for the Six Months Ended 30 September 2022
Nov 15, 2022: Bausch + Lomb reports more than 58 million units of contact lens, lens care and eye care materials collected through ONE By ONE and Biotrue eye care recycling programs
Nov 02, 2022: Fielmann AG: ad hoc announcement for the third quarter
Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring
Oct 13, 2022: Novartis to cut its Irish workforce by up to 25%
Oct 11, 2022: Elegance Optical International Announces Resignation of Executive Directors, Chairman of the Board and Authorised Representative
Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2
Sep 29, 2022: 1-800 Contacts Appoints Angie Balfour as Chief People Officer
Sep 29, 2022: QITIAN Technology Group Announces on the Appointment of Senior Management Personnel
Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations
Sep 28, 2022: Shanghai Conant Optical Co Ltd announced interim report for 2022
Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting